Cited by 254

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

The therapeutic potential of chemical chaperones in protein folding diseases

Open access

Cortez, Leonardo, Sim, Valerie·2014·Prion

Open this paper in CoChat — free account

Abstract

Several neurodegenerative diseases are caused by defects in protein folding, including Alzheimer, Parkinson, Huntington, and prion diseases. Once a disease-specific protein misfolds, it can then form toxic aggregates which accumulate in the brain, leading to neuronal dysfunction, cell death, and clinical symptoms. Although significant advances have been made toward understanding the mechanisms of protein aggregation, there are no curative treatments for any of these diseases. Since protein misfolding and the accumulation of aggregates are the most upstream events in the pathological cascade, rescuing or stabilizing the native conformations of proteins is an obvious therapeutic strategy. In recent years, small molecules known as chaperones have been shown to be effective in reducing levels of misfolded proteins, thus minimizing the accumulation of aggregates and their downstream pathological consequences. Chaperones are classified as molecular, pharmacological, or chemical. In this mini-review we summarize the modes of action of different chemical chaperones and discuss evidence for their efficacy in the treatment of protein folding diseases in vitro and in vivo.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.4161/pri.28938

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Living with Water Stress: Evolution of Osmolyte Systems
Yancey, P. H., Clark, M. E., Hand, S. C., Bowlus, R. D., & Somero, G. N. (1982) · Science · doi:10.1126/science.7112124 · Cited by 3,740
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Modulation of neurodegeneration by molecular chaperones
Muchowski, P. J., & Wacker, J. L. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1587 · Cited by 1,024
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease
Hockly, E., Richon, V. M., Woodman, B., Smith, D. L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi-Noori, S., Mahal, A., Lowden, P. A. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437870100 · Cited by 845
Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease
Tanaka, M., Machida, Y., Niu, S., Ikeda, T., Jana, N. R., Doi, H., Kurosawa, M., Nekooki, M., & Nukina, N. (2004) · Nature Medicine · doi:10.1038/nm985 · Cited by 782
Bile acids as regulatory molecules
Hylemon, P. B., Zhou, H., Pandak, W. M., Ren, S., Gil, G., & Dent, P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900007-jlr200 · Cited by 694 · cited 1×
“200 Prion volume 8 issue 2 that encode proteins involved in the regulation of glucose, fatty acid, lipoprotein synthesis, energy metabolism, and the regulation of their own synthesis.(51) In vitro data There is in vitro evidence to support a chaperone activity for BAs.”
Background
Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice
Ferrante, R. J., Kubilus, J. K., Lee, J., Ryu, H., Beesen, A., Zucker, B., Smith, K., Kowall, N. W., Ratan, R. R., Luthi-Carter, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09418.2003 · Cited by 693
A molecular mechanism for osmolyte-induced protein stability
Street, T. O., Bolen, D. W., & Rose, G. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606236103 · Cited by 667
A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.
Rodrigues, C. M., Fan, G., Ma, X., Kren, B. T., & Steer, C. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1325 · Cited by 520
Chemical Chaperones Regulate Molecular Chaperones in Vitro and in Cells under Combined Salt and Heat Stresses
Diamant, S., Eliahu, N., Rosenthal, D., & Goloubinoff, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103081200 · Cited by 461
Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease
Gardian, G., Browne, S. E., Choi, D.-K., Klivenyi, P., Gregorio, J., Kubilus, J. K., Ryu, H., Langley, B., Ratan, R. R., Ferrante, R. J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410210200 · Cited by 456
Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction
Ren, M., Leng, Y., Jeong, M., Leeds, P. R., & Chuang, D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02406.x · Cited by 378
Why do some organisms use a urea-methylamine mixture as osmolyte? Thermodynamic compensation of urea and trimethylamine N-oxide interactions with protein
Lin, T.-Y., & Timasheff, S. N. (1994) · Biochemistry · doi:10.1021/bi00208a021 · Cited by 371
Forcing Thermodynamically Unfolded Proteins to Fold
Baskakov, I., & Bolen, D. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.4831 · Cited by 360
Ursodeoxycholic Acid May Inhibit Deoxycholic Acid-Induced Apoptosis by Modulating Mitochondrial Transmembrane Potential and Reactive Oxygen Species Production
Rodrigues, C. M. P., Fan, G., Wong, P. Y., Kren, B. T., & Steer, C. J. (1998) · Molecular Medicine · doi:10.1007/bf03401914 · Cited by 334
Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration
Geier, A., Wagner, M., Dietrich, C. G., & Trauner, M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.04.014 · Cited by 314
Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease
Keene, C. D., Rodrigues, C. M. P., Eich, T., Chhabra, M. S., Steer, C. J., & Low, W. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162362299 · Cited by 306
Chemical chaperones interfere with the formation of scrapie prion protein.
Tatzelt, J., Prusiner, S. B., & Welch, W. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01027.x · Cited by 294
Pharmacological chaperones: potential treatment for conformational diseases
Bernier, V., Lagacé, M., Bichet, D. G., & Bouvier, M. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.05.003 · Cited by 283
Manipulating the Amyloid-β Aggregation Pathway with Chemical Chaperones
Yang, D.-S., Yip, C. M., Huang, T. H. J., Chakrabartty, A., & Fraser, P. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32970 · Cited by 268
Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4‐phenylbutyrate, a chemical chaperone
Inden, M., Kitamura, Y., Takeuchi, H., Yanagida, T., Takata, K., Kobayashi, Y., Taniguchi, T., Yoshimoto, K., Kaneko, M., Okuma, Y., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04440.x · Cited by 260
Protein rescue from aggregates by powerful molecular chaperone machines
Doyle, S. M., Genest, O., & Wickner, S. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3660 · Cited by 251
Hsp70 and Its Molecular Role in Nervous System Diseases
Turturici, G., Sconzo, G., & Geraci, F. (2011) · Biochemistry Research International · doi:10.1155/2011/618127 · Cited by 246
Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate
Dover, G., Brusilow, S., & Charache, S. (1994) · Blood · doi:10.1182/blood.v84.1.339.339 · Cited by 232
Trimethylamine‐ N ‐oxide‐induced folding of α‐synuclein
Uversky, V. N., Li, J., & Fink, A. L. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03121-0 · Cited by 208
Evidence of CFTR Function in Cystic Fibrosis after Systemic Administration of 4-Phenylbutyrate
Zeitlin, P. L., Diener-West, M., Rubenstein, R. C., Boyle, M. P., Lee, C. K. K., & Brass-Ernst, L. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0639 · Cited by 194
TUDCA, a Bile Acid, Attenuates Amyloid Precursor Protein Processing and Amyloid-β Deposition in APP/PS1 Mice
Nunes, A. F., Amaral, J. D., Lo, A. C., Fonseca, M. B., Viana, R. J. S., Callaerts-Vegh, Z., D’Hooge, R., & Rodrigues, C. M. P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8256-y · Cited by 192
Hot spots in prion protein for pathogenic conversion
Kuwata, K., Nishida, N., Matsumoto, T., Kamatari, Y. O., Hosokawa-Muto, J., Kodama, K., Nakamura, H. K., Kimura, K., Kawasaki, M., Takakura, Y., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702671104 · Cited by 181
Phenylbutyrate Up-regulates the DJ-1 Protein and Protects Neurons in Cell Culture and in Animal Models of Parkinson Disease
Zhou, W., Bercury, K., Cummiskey, J., Luong, N., Lebin, J., & Freed, C. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.211029 · Cited by 178
Chemical Chaperones Reduce Endoplasmic Reticulum Stress and Prevent Mutant HFE Aggregate Formation
de Almeida, S. F., Picarote, G., Fleming, J. V., Carmo-Fonseca, M., Azevedo, J. E., & de Sousa, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702672200 · Cited by 166
Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease
Castro-Caldas, M., Carvalho, A. N., Rodrigues, E., Henderson, C. J., Wolf, C. R., Rodrigues, C. M. P., & Gama, M. J. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8295-4 · Cited by 156
Phase 2 study of sodium phenylbutyrate in ALS
Cudkowicz, M., Andres, P. L., MacDonald, S., Bedlack, R., Choudry, R., Brown, R. H., Jr., Zhang, H., Schoenfeld, D., Shefner, J. M., Matson, S. A., et al. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802320487 · Cited by 154
Sodium Phenylbutyrate Controls Neuroinflammatory and Antioxidant Activities and Protects Dopaminergic Neurons in Mouse Models of Parkinson’s Disease
Roy, A., Ghosh, A., Jana, A., Liu, X., Brahmachari, S., Gendelman, H. E., & Pahan, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038113 · Cited by 149
Spinal Muscular Atrophy: From Gene to Therapy
Wirth, B., Brichta, L., & Hahnen, E. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.06.008 · Cited by 142
Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders
Konsoula, Z., & Barile, F. A. (2012) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2012.08.001 · Cited by 141
Tauroursodeoxycholic Acid Prevents Bax-Induced Membrane Perturbation and CytochromecRelease in Isolated Mitochondria
Rodrigues, C. M. P., Solá, S., Sharpe, J. C., Moura, J. J. G., & Steer, C. J. (2003) · Biochemistry · doi:10.1021/bi026979d · Cited by 125
The Atropisomer-Selective Ring Cleavage of Helically Distorted, Configuratively Unstable Biaryl Lactones with a Chiral Metallated N -Nucleophile - the Complete PM3 Mechanistic Course and its Video Presentation
Bringmann, G., G�ssregen, S., Vitt, D., & Stowasser, R. (1998) · Journal of Molecular Modeling · doi:10.1007/s0089480040165 · Cited by 113
Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice
Wiley, J. C., Pettan-Brewer, C., & Ladiges, W. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00680.x · Cited by 108
Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease
Ramalho, R. M., Viana, R. J. S., Low, W. C., Steer, C. J., & Rodrigues, C. M. P. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.001 · Cited by 107
Sodium phenylbutyrate in Huntington's disease: A dose‐finding study
Hogarth, P., Lovrečić, L., & Krainc, D. (2007) · Movement Disorders · doi:10.1002/mds.21632 · Cited by 89
Structure–function analysis of the tertiary bile acid TUDCA for the resolution of endoplasmic reticulum stress in intestinal epithelial cells
Berger, E., & Haller, D. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.043 · Cited by 87
Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes
Azzaroli, F., Mehal, W. Z., Soroka, C. J., Wang, L., Lee, J., Crispe, I. N., & Boyer, J. L. (2002) · Hepatology · doi:10.1053/jhep.2002.34511 · Cited by 84
Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line demonstrates a major influence on heat-shock proteins
Wright, J. M., Zeitlin, P. L., Cebotaru, L., Guggino, S. E., & Guggino, W. B. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00160.2003 · Cited by 82
Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors
Camacho, L. H., Olson, J., Tong, W. P., Young, C. W., Spriggs, D. R., & Malkin, M. G. (2006) · Investigational New Drugs · doi:10.1007/s10637-006-9017-4 · Cited by 81
Preventing Misfolding of the Prion Protein by Trimethylamine N-Oxide
Bennion, B. J., DeMarco, M. L., & Daggett, V. (2004) · Biochemistry · doi:10.1021/bi0486379 · Cited by 79
Osmolyte‐induced conformational changes in the Hsp90 molecular chaperone
Street, T. O., Krukenberg, K. A., Rösgen, J., Bolen, D. W., & Agard, D. A. (2009) · Protein Science · doi:10.1002/pro.282 · Cited by 76
4-Phenylbutyric acid protects against neuronal cell death by primarily acting as a chemical chaperone rather than histone deacetylase inhibitor
Mimori, S., Ohtaka, H., Koshikawa, Y., Kawada, K., Kaneko, M., Okuma, Y., Nomura, Y., Murakami, Y., & Hamana, H. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.001 · Cited by 72
Phenylbutyric Acid Rescues Endoplasmic Reticulum Stress-Induced Suppression of APP Proteolysis and Prevents Apoptosis in Neuronal Cells
Wiley, J. C., Meabon, J. S., Frankowski, H., Smith, E. A., Schecterson, L. C., Bothwell, M. A., & Ladiges, W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009135 · Cited by 72
Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of Familial Amyloidotic Polyneuropathy
Macedo, B., Batista, A. R., Ferreira, N., Almeida, M. R., & Saraiva, M. J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.05.005 · Cited by 70
Contribution of simple saccharides to the stabilization of amyloid structure
Fung, J., Darabie, A. A., & McLaurin, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.068 · Cited by 68
The Bile Acid Tauroursodeoxycholic Acid Modulates Phosphorylation and Translocation of Bad via Phosphatidylinositol 3-Kinase in Glutamate-Induced Apoptosis of Rat Cortical Neurons
Castro, R. E., Solá, S., Ramalho, R. M., Steer, C. J., & Rodrigues, C. M. P. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070532 · Cited by 66
Phenylbutyrate is a Multifaceted Drug that Exerts Neuroprotective Effects and Reverses the Alzheimer´s Disease-like Phenotype of a Commonly Used Mouse Model
Cuadrado‐Tejedor, M., Ricobaraza, A., Torrijo, R., Franco, R., & García‐Osta, A. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319280006 · Cited by 66
Tauroursodeoxycholic acid prevents E22Q Alzheimer’s Aβ toxicity in human cerebral endothelial cells
Viana, R. J. S., Nunes, A. F., Castro, R. E., Ramalho, R. M., Meyerson, J. L., Fossati, S., Ghiso, J. A., Rostagno, A. A., & Rodrigues, C. M. P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-8746-x · Cited by 64
Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrP C to PrP res
Kim, N., Choi, J.-K., Jeong, B., Kim, J., Kwon, M.-S., Carp, R. I., & Kim, Y. (2005) · The FASEB Journal · doi:10.1096/fj.04-2117fje · Cited by 61
Perspectives on molecular targeted therapies and clinical trials for neurodegenerative diseases
Katsuno, M., Tanaka, F., & Sobue, G. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301307 · Cited by 54
Long-term Phenylbutyrate administration prevents memory deficits in Tg2576 mice by decreasing A Beta
Garcia-Osta, A. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/e340 · Cited by 50
Variety of Antiprion Compounds Discovered through an In Silico Screen Based on Cellular-Form Prion Protein Structure: Correlation between Antiprion Activity and Binding Affinity
Hosokawa‐Muto, J., Kamatari, Y. O., Nakamura, H. K., & Kuwata, K. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01112-08 · Cited by 49
Defining the Mechanism of Action of 4-Phenylbutyrate to Develop a Small-Molecule-Based Therapy for Alzheimers Disease
Cuadrado‐Tejedor, M., García‐Osta, A., Ricobaraza, A., et al. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711798347315 · Cited by 40
Molecular Chaperones in Health and Disease
Starke, K., & Gaestel, M. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-29717-0 · Cited by 35
Amyloid beta-HSP60 peptide conjugate vaccine treats a mouse model of Alzheimer's disease
Nemirovsky, A., Fisher, Y., Baron, R., Cohen, I. R., & Monsonego, A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.03.033 · Cited by 20
Cholesterol-derived bile acids enhance the chaperone activity of α-crystallins
Song, S., Liang, J. J. ‐., Mulhern, M. L., Madson, C. J., & Shinohara, T. (2011) · Cell Stress and Chaperones · doi:10.1007/s12192-011-0259-5 · Cited by 15

Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Breijyeh, Z., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25245789 · Cited by 2,789
Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases
Ren, J., Bi, Y., Sowers, J. R., Hetz, C., & Zhang, Y. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00511-w · Cited by 708
The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome system
Ji, C. H., Kim, H. Y., Lee, M. J., Heo, A. J., Park, D. Y., Lim, S., Shin, S., Ganipisetti, S., Yang, W. S., Jung, C. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28520-4 · Cited by 350
Thyroid Hormone Transporters
Groeneweg, S., van Geest, F. S., Peeters, R. P., Heuer, H., & Visser, W. E. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz008 · Cited by 216
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors
Lv, X., Lu, X., Cao, J., Luo, Q., Ding, Y., Peng, F., Pataer, A., Lu, D., Han, D., Malmberg, E., et al. (2023) · Science · doi:10.1126/science.abn4180 · Cited by 123

See all 254

Authors: Cortez, L., & Sim, V.
Venue: Prion
Publisher: Informa UK Limited
Published: 2014-03
Volume: 8
Issue: 2
Pages: 197-202
ISSN: 1933-6896 (ISSN-L)
1933-690X
DOI: 10.4161/pri.28938
OpenAlex: W2065631672
Cited by: 254
References: 62
FWCI: 5.23
Type: journal article
Language: en
Open access: bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

The therapeutic potential of chemical chaperones in protein folding diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources